GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024

Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

by Genomic PressAlysson R. Muotri, Ph.D., University of California, San Diego, U.S. Credit:Brain Medicine(2024). https://doi.org/10.61373/bm024k.0082In an interviewpublishedin&

Updated on: October 16,2024

Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience

by Genomic PressAlysson R. Muotri, Ph.D., University of California, San Diego, U.S. Credit:Brain Medicine(2024). https://doi.org/10.61373/bm024k.0082In an interviewpublishedin&

Updated on:October 16,2024

People with dementia and the right to independent life

by Risto Löf,University of Eastern FinlandTuija Alava, an expert by experience for Pohjois-Savon Muisti, was diagnosed with Alzheimer’s disease while still in working life. Alava lives alone and

Updated on: May 08,2024

People with dementia and the right to independent life

by Risto Löf,University of Eastern FinlandTuija Alava, an expert by experience for Pohjois-Savon Muisti, was diagnosed with Alzheimer’s disease while still in working life. Alava lives alone and

Updated on:May 08,2024

Uncovering the molecular mechanism behind synapse loss in Alzheimer's disease

by Korea Brain Research InstituteCredit: Unsplash/CC0 Public DomainKorea Brain Research Institute (KBRI, Pann-Ghill Suh (President)) announced that Dr. Kea Joo Lee and Dr. You-Na Jang of the Neural Ci

Updated on: July 01,2024

Uncovering the molecular mechanism behind synapse loss in Alzheimer's disease

by Korea Brain Research InstituteCredit: Unsplash/CC0 Public DomainKorea Brain Research Institute (KBRI, Pann-Ghill Suh (President)) announced that Dr. Kea Joo Lee and Dr. You-Na Jang of the Neural Ci

Updated on:July 01,2024

Risk for dementia reduced in association with antihypertensive use

by Elana GotkineAntihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 inJAMA Network Open.Matt

Updated on: March 02,2024

Risk for dementia reduced in association with antihypertensive use

by Elana GotkineAntihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 inJAMA Network Open.Matt

Updated on:March 02,2024

Measuring changes to the male brain after fathering a child

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers with members from Instituto de Investigación Sanitaria Gregorio Marañón, the University of Southern California and t

Updated on: February 05,2024

Measuring changes to the male brain after fathering a child

by Bob Yirka , Medical XpressCredit: Pixabay/CC0 Public DomainA team of researchers with members from Instituto de Investigación Sanitaria Gregorio Marañón, the University of Southern California and t

Updated on:February 05,2024

Study reveals brain's role in starting meals through GABA, dopamine

by Taylor Barnes,Baylor College of MedicineCredit:Metabolism(2024). DOI: 10.1016/j.metabol.2024.156099When you are feeling hungry, the brain takes the necessary steps toward consumin

Updated on: January 15,2025

Study reveals brain's role in starting meals through GABA, dopamine

by Taylor Barnes,Baylor College of MedicineCredit:Metabolism(2024). DOI: 10.1016/j.metabol.2024.156099When you are feeling hungry, the brain takes the necessary steps toward consumin

Updated on:January 15,2025

Promoting exercise rehabilitation as new and powerful tool for managing symptoms of multiple sclerosis

by Kessler FoundationDr. Brian Sandroff monitors a research participant in an MS exercise study at Kessler Foundation. Credit: Kessler FoundationCiting recent evidence, experts in rehabilitation resea

Updated on: February 18,2024

Promoting exercise rehabilitation as new and powerful tool for managing symptoms of multiple sclerosis

by Kessler FoundationDr. Brian Sandroff monitors a research participant in an MS exercise study at Kessler Foundation. Credit: Kessler FoundationCiting recent evidence, experts in rehabilitation resea

Updated on:February 18,2024

Blocking inflammation prevents cell death, improves memory in Alzheimer's disease

by University of California, IrvineA brain tissue sample from Kim Green’s study show microglia (red) and plaques (green). Credit: Green lab / UCIUsing a drug compound created to treat cance

Updated on: February 28,2024

Blocking inflammation prevents cell death, improves memory in Alzheimer's disease

by University of California, IrvineA brain tissue sample from Kim Green’s study show microglia (red) and plaques (green). Credit: Green lab / UCIUsing a drug compound created to treat cance

Updated on:February 28,2024

Unraveling the mysteries of the presynapse with super resolution microscopy

by Queensland Brain Institutea Graphical representation of the Dual-pulse sub-diffractional Tracking of Internalized Molecules (DsdTIM) protocol. b Representative epifluorescence image of an axonal se

Updated on: March 28,2024

Unraveling the mysteries of the presynapse with super resolution microscopy

by Queensland Brain Institutea Graphical representation of the Dual-pulse sub-diffractional Tracking of Internalized Molecules (DsdTIM) protocol. b Representative epifluorescence image of an axonal se

Updated on:March 28,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on: April 16,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on:April 16,2024

Research suggests symptomatic Alzheimer's treatments may reduce care costs

by Alzheimer's Research UKNew research has linked the use of existing treatments for Alzheimer's to lower healthcare costs and increased survival for people with the disease. The study, w

Updated on: March 07,2024

Research suggests symptomatic Alzheimer's treatments may reduce care costs

by Alzheimer's Research UKNew research has linked the use of existing treatments for Alzheimer's to lower healthcare costs and increased survival for people with the disease. The study, w

Updated on:March 07,2024